An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

dc.contributor.authorWinston Dunn
dc.contributor.authorYanming Li
dc.contributor.authorAshwani K. Singal
dc.contributor.authorDouglas A. Simonetto
dc.contributor.authorLuis Antonio Díaz
dc.contributor.authorFrancisco Idalsoaga
dc.contributor.authorGustavo Ayares
dc.contributor.authorJorge Arnold
dc.contributor.authorMaría Ayala-Valverde
dc.contributor.authorDiego Pérez
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:20:00Z
dc.date.available2026-03-22T14:20:00Z
dc.date.issued2024
dc.descriptionCitaciones: 13
dc.description.abstractHarnessing artificial intelligence within a global consortium, we pioneered a scoring system excelling over traditional models for 30 and 90-day AH mortality predictions. Beneficial for clinical trials, steroid therapy, and transplant indications, it's accessible at: https://aihepatology.shinyapps.io/ALCHAIN/ .
dc.identifier.doi10.1097/hep.0000000000000883
dc.identifier.urihttps://doi.org/10.1097/hep.0000000000000883
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/45900
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofHepatology
dc.sourceUniversity of Kansas Medical Center
dc.subjectMedicine
dc.subjectCohort
dc.subjectMachine learning
dc.subjectRetrospective cohort study
dc.subjectMortality rate
dc.subjectCohort study
dc.subjectAlcoholic hepatitis
dc.subjectArtificial intelligence
dc.subjectInternal medicine
dc.subjectDemography
dc.titleAn artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study
dc.typearticle

Files